HEMINGWAY INNOVATION ATLAS
An independent series assessing the state of mental health innovations.
These reports aim to create greater transparency on the state of an innovation and to make recommendations on where efforts would move the innovation forward and provide better outcomes for patients.
ABOUT THE SERIES
The Hemingway Innovation Atlas takes a systems lens to analysing emerging approaches for treating mental disorders.
Each assessment brings together the latest clinical evidence, scientific and technological advances, commercial and investment dynamics, health system economics, and real-world implementation.
Its goal is to create greater transparency on the state of an innovation and to make recommendations on where efforts would move the innovation forward and provide better outcomes for patients. While researchers, clinicians, developers, investors, regulators and health systems each see part of an innovation’s picture, they often work from different evidence and incentives.
The Atlas looks at the whole system, across countries and across very different kinds of innovation, from medicines to devices and digital tools.
It uses a single framework, which lets very different fields be compared. Each briefing applies this framework to one innovation, assessing where it stands and what is holding it back.
Each report offers an independent, evidence-led perspective on where an innovation stands, the developments that matter most, and the opportunities and decisions that will shape its future.
PUBLISHED REPORTS
December 2026
Transcranial Magnetic Stimulation (TMS)
January 2027
Conversational AI
2027
Metabolic Psychiatry
You will also receive our free, weekly newsletter on what’s happening in mental health.
THE FRAMEWORK
Our Maturity Framework assesses each innovation through five lenses. It aims to assess where an innovation stands today, what is holding it back and how it compares to other innovations in mental health.
01
Effectiveness on Meaningful Outcomes
Does it work, and how confident are we?
02
Development Pathway
How mature is the intervention and its requirements for reproducible delivery?
03
Capital Pathway
How mature are the financing and commercialisation pathways supporting development, delivery and scale?
04
Health & System Value
What value does it create, and at what cost?
05
Adoption Profile
Where do systems and payers fund it, and on what terms?
PRO
Members' research briefings. Each report comes with a live discussion and Q&A with its authors.

We host live discussions on the findings from these reports as well as other areas of mental health innovation. Become a Hemingway Pro member to join these events.